Logo image of SAM

BOSTON BEER COMPANY INC-A (SAM) Stock Fundamental Analysis

NYSE:SAM - New York Stock Exchange, Inc. - US1005571070 - Common Stock - Currency: USD

198.34  -0.29 (-0.15%)

After market: 196.06 -2.28 (-1.15%)

Fundamental Rating

5

SAM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. SAM has an excellent financial health rating, but there are some minor concerns on its profitability. SAM has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SAM was profitable.
SAM had a positive operating cash flow in the past year.
Each year in the past 5 years SAM has been profitable.
Each year in the past 5 years SAM had a positive operating cash flow.
SAM Yearly Net Income VS EBIT VS OCF VS FCFSAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

SAM has a Return On Assets (5.77%) which is in line with its industry peers.
SAM's Return On Equity of 7.97% is in line compared to the rest of the industry. SAM outperforms 50.00% of its industry peers.
With a decent Return On Invested Capital value of 11.71%, SAM is doing good in the industry, outperforming 65.63% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SAM is below the industry average of 11.61%.
The 3 year average ROIC (8.12%) for SAM is below the current ROIC(11.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.77%
ROE 7.97%
ROIC 11.71%
ROA(3y)4.95%
ROA(5y)5.95%
ROE(3y)6.63%
ROE(5y)8.26%
ROIC(3y)8.12%
ROIC(5y)8.73%
SAM Yearly ROA, ROE, ROICSAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With a Profit Margin value of 3.50%, SAM perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
SAM's Profit Margin has declined in the last couple of years.
The Operating Margin of SAM (8.32%) is worse than 68.75% of its industry peers.
In the last couple of years the Operating Margin of SAM has declined.
Looking at the Gross Margin, with a value of 45.41%, SAM is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of SAM has declined.
Industry RankSector Rank
OM 8.32%
PM (TTM) 3.5%
GM 45.41%
OM growth 3Y39.49%
OM growth 5Y-8.36%
PM growth 3Y61.25%
PM growth 5Y-19.42%
GM growth 3Y4.62%
GM growth 5Y-2.01%
SAM Yearly Profit, Operating, Gross MarginsSAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SAM is creating some value.
SAM has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SAM has been reduced compared to 5 years ago.
SAM has a worse debt/assets ratio than last year.
SAM Yearly Shares OutstandingSAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SAM Yearly Total Debt VS Total AssetsSAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

SAM has an Altman-Z score of 6.37. This indicates that SAM is financially healthy and has little risk of bankruptcy at the moment.
SAM has a Altman-Z score of 6.37. This is amongst the best in the industry. SAM outperforms 84.38% of its industry peers.
There is no outstanding debt for SAM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.37
ROIC/WACC1.3
WACC9.03%
SAM Yearly LT Debt VS Equity VS FCFSAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

SAM has a Current Ratio of 1.72. This is a normal value and indicates that SAM is financially healthy and should not expect problems in meeting its short term obligations.
SAM has a Current ratio of 1.72. This is in the better half of the industry: SAM outperforms 62.50% of its industry peers.
A Quick Ratio of 1.12 indicates that SAM should not have too much problems paying its short term obligations.
SAM's Quick ratio of 1.12 is fine compared to the rest of the industry. SAM outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.12
SAM Yearly Current Assets VS Current LiabilitesSAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.23% over the past year.
Measured over the past years, SAM shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.56% on average per year.
The Revenue has been growing slightly by 0.79% in the past year.
Measured over the past years, SAM shows a quite strong growth in Revenue. The Revenue has been growing by 10.00% on average per year.
EPS 1Y (TTM)28.23%
EPS 3Y32.41%
EPS 5Y-0.56%
EPS Q2Q%107.69%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y-0.73%
Revenue growth 5Y10%
Sales Q2Q%6.53%

3.2 Future

Based on estimates for the next years, SAM will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.72% on average per year.
SAM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.56% yearly.
EPS Next Y3.13%
EPS Next 2Y10.91%
EPS Next 3Y13.59%
EPS Next 5Y14.72%
Revenue Next Year2.38%
Revenue Next 2Y2.49%
Revenue Next 3Y2.56%
Revenue Next 5Y3.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SAM Yearly Revenue VS EstimatesSAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
SAM Yearly EPS VS EstimatesSAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.41, which indicates a rather expensive current valuation of SAM.
SAM's Price/Earnings ratio is in line with the industry average.
SAM is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 17.72, the valuation of SAM can be described as rather expensive.
SAM's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.76. SAM is around the same levels.
Industry RankSector Rank
PE 19.41
Fwd PE 17.72
SAM Price Earnings VS Forward Price EarningsSAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SAM's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SAM is cheaper than 84.38% of the companies in the same industry.
84.38% of the companies in the same industry are more expensive than SAM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.94
EV/EBITDA 7.82
SAM Per share dataSAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SAM does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as SAM's earnings are expected to grow with 13.59% in the coming years.
PEG (NY)6.21
PEG (5Y)N/A
EPS Next 2Y10.91%
EPS Next 3Y13.59%

0

5. Dividend

5.1 Amount

No dividends for SAM!.
Industry RankSector Rank
Dividend Yield N/A

BOSTON BEER COMPANY INC-A

NYSE:SAM (7/8/2025, 8:04:00 PM)

After market: 196.06 -2.28 (-1.15%)

198.34

-0.29 (-0.15%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)07-24 2025-07-24/amc
Inst Owners84.22%
Inst Owner Change0%
Ins Owners9.5%
Ins Owner Change16.48%
Market Cap2.21B
Analysts66
Price Target264.62 (33.42%)
Short Float %10.25%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)132.38%
Min EPS beat(2)-27.29%
Max EPS beat(2)292.05%
EPS beat(4)2
Avg EPS beat(4)64.45%
Min EPS beat(4)-27.29%
Max EPS beat(4)292.05%
EPS beat(8)4
Avg EPS beat(8)1477.66%
EPS beat(12)4
Avg EPS beat(12)951.74%
EPS beat(16)4
Avg EPS beat(16)694.22%
Revenue beat(2)2
Avg Revenue beat(2)2.9%
Min Revenue beat(2)2.35%
Max Revenue beat(2)3.45%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-4.01%
Max Revenue beat(4)3.45%
Revenue beat(8)5
Avg Revenue beat(8)-0.16%
Revenue beat(12)8
Avg Revenue beat(12)1.28%
Revenue beat(16)9
Avg Revenue beat(16)0.05%
PT rev (1m)-1.77%
PT rev (3m)-3.32%
EPS NQ rev (1m)-0.82%
EPS NQ rev (3m)-14.32%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.9%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)-0.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.14%
Valuation
Industry RankSector Rank
PE 19.41
Fwd PE 17.72
P/S 1.08
P/FCF 11.94
P/OCF 8.65
P/B 2.47
P/tB 2.88
EV/EBITDA 7.82
EPS(TTM)10.22
EY5.15%
EPS(NY)11.19
Fwd EY5.64%
FCF(TTM)16.61
FCFY8.38%
OCF(TTM)22.93
OCFY11.56%
SpS183.03
BVpS80.45
TBVpS68.92
PEG (NY)6.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.77%
ROE 7.97%
ROCE 17%
ROIC 11.71%
ROICexc 13.82%
ROICexgc 16.29%
OM 8.32%
PM (TTM) 3.5%
GM 45.41%
FCFM 9.08%
ROA(3y)4.95%
ROA(5y)5.95%
ROE(3y)6.63%
ROE(5y)8.26%
ROIC(3y)8.12%
ROIC(5y)8.73%
ROICexc(3y)10.19%
ROICexc(5y)10.53%
ROICexgc(3y)12.36%
ROICexgc(5y)13.08%
ROCE(3y)11.79%
ROCE(5y)12.67%
ROICexcg growth 3Y51.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y53.78%
ROICexc growth 5Y1.55%
OM growth 3Y39.49%
OM growth 5Y-8.36%
PM growth 3Y61.25%
PM growth 5Y-19.42%
GM growth 3Y4.62%
GM growth 5Y-2.01%
F-Score7
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 75.44%
Cap/Sales 3.45%
Interest Coverage 250
Cash Conversion 97.13%
Profit Quality 259.06%
Current Ratio 1.72
Quick Ratio 1.12
Altman-Z 6.37
F-Score7
WACC9.03%
ROIC/WACC1.3
Cap/Depr(3y)88.4%
Cap/Depr(5y)136.69%
Cap/Sales(3y)3.77%
Cap/Sales(5y)5.31%
Profit Quality(3y)238.48%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.23%
EPS 3Y32.41%
EPS 5Y-0.56%
EPS Q2Q%107.69%
EPS Next Y3.13%
EPS Next 2Y10.91%
EPS Next 3Y13.59%
EPS Next 5Y14.72%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y-0.73%
Revenue growth 5Y10%
Sales Q2Q%6.53%
Revenue Next Year2.38%
Revenue Next 2Y2.49%
Revenue Next 3Y2.56%
Revenue Next 5Y3.56%
EBIT growth 1Y12.55%
EBIT growth 3Y38.47%
EBIT growth 5Y0.81%
EBIT Next Year64.71%
EBIT Next 3Y26.1%
EBIT Next 5Y23.19%
FCF growth 1Y33.28%
FCF growth 3YN/A
FCF growth 5Y15.22%
OCF growth 1Y14.62%
OCF growth 3Y64.13%
OCF growth 5Y6.91%